Literature DB >> 12379710

Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection.

Thomas A Moore1, Michelle L Perry, Andrew G Getsoian, Michael W Newstead, Theodore J Standiford.   

Abstract

Klebsiella pneumoniae is a leading cause of both community-acquired and nosocomial gram-negative-bacterial pneumonia. A further clinical complication of pulmonary K. pneumoniae infection is dissemination of bacteria from the lung into the peripheral blood, resulting in bacteremia concurrent with the localized pulmonary infection. Here, we report studies detailing the divergent role of gamma interferon (IFN-gamma) in pulmonary versus systemic K. pneumoniae infection. Intratracheal inoculation of IFN-gamma knockout mice resulted in significantly increased mortality compared to that observed for wild-type infected animals. Increased mortality correlated with a 100-fold increase in pulmonary bacteria within 2 days postinfection and upregulation of lung-associated interleukin-10 (IL-10) mRNA. Interestingly, IFN-gamma knockout mice had a twofold reduction in plasma aminospartate transferase activity, indicating diminished liver injury following peripheral blood bacterial dissemination. To study the host response towards blood-borne bacteria in the absence of the ongoing pulmonary infection, intravenous inoculation studies were initiated. IFN-gamma knockout mice were no more susceptible to intravenous infection than their wild-type counterparts. The consistent observation in IFN-gamma knockout mice was for improved survival correlating with increased clearance of blood- and liver-associated bacteria. Intravenous inoculation resulted in a two- to threefold increase in hepatic IL-10 production 24 and 48 h postinfection. Liver injury was also significantly reduced in IFN-gamma knockout mice. These data indicate that IFN-gamma secretion is a critical mediator in the resolution of localized gram-negative pulmonary pneumonia. Surprisingly, host responses towards systemic infection with the same bacteria appear to be IFN-gamma independent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379710      PMCID: PMC130357          DOI: 10.1128/IAI.70.11.6310-6318.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.

Authors:  T van der Poll; C V Keogh; W A Buurman; S F Lowry
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

2.  Klebsiella bacteraemia: community versus nosocomial infection.

Authors:  A M Yinnon; A Butnaru; D Raveh; Z Jerassy; B Rudensky
Journal:  QJM       Date:  1996-12

Review 3.  Current and future clinical applications of interferon-gamma in host antimicrobial defense.

Authors:  H W Murray
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

4.  Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia.

Authors:  J B Rubins; C Pomeroy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 5.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

7.  Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes.

Authors:  A Kano; Y Watanabe; N Takeda; S Aizawa; T Akaike
Journal:  J Biochem       Date:  1997-04       Impact factor: 3.387

8.  Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils.

Authors:  S H Gregory; A J Sagnimeni; E J Wing
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

9.  Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia.

Authors:  L L Laichalk; S L Kunkel; R M Strieter; J M Danforth; M B Bailie; T J Standiford
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

10.  Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice.

Authors:  L Santucci; S Fiorucci; M Chiorean; P M Brunori; F M Di Matteo; A Sidoni; G Migliorati; A Morelli
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

View more
  45 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.

Authors:  Haijun Tian; Avi Groner; Marianne Boes; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia.

Authors:  Xianying Zeng; Thomas A Moore; Michael W Newstead; Jane C Deng; Steven L Kunkel; Andrew D Luster; Theodore J Standiford
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  The IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection.

Authors:  Frédéric Pène; Andrea Paun; Søren Ulrik Sønder; Nimisha Rikhi; Hongshan Wang; Estefania Claudio; Ulrich Siebenlist
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

Review 5.  Vaccine approaches for multidrug resistant Gram negative infections.

Authors:  Brian Campfield; Kong Chen; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2014-03-15       Impact factor: 7.486

6.  Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia.

Authors:  Xin Xu; Ido D Weiss; Hongwei H Zhang; Satya P Singh; Thomas A Wynn; Mark S Wilson; Joshua M Farber
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

7.  Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia.

Authors:  Anna L Cogen; Thomas A Moore
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

8.  Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection.

Authors:  Thomas A Moore; Michelle L Perry; Andrew G Getsoian; Christine L Monteleon; Anna L Cogen; Theodore J Standiford
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection.

Authors:  Jane C Deng; Xianying Zeng; Michael Newstead; Thomas A Moore; Wan C Tsai; Victor J Thannickal; Theodore J Standiford
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

10.  Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice.

Authors:  Helen Y Lau; Gary B Huffnagle; Thomas A Moore
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.